Global Therapeutic Nuclear Medicines Market Growth, Share, Size, Trends and Forecast (2024 - 2030)
Segmented by Treatment Type;
Radium-223, Iodine-131, Leutitium-177, Yttrium-90, Samarium-153, Strontium-89, Rhenium-188+ Rhenium-186, Erbium-169, Phosphorus-32 and others.Segmented by Disease;
prostate cancer, painful bone metastases, thyroid cancer, neuroblastoma, synovitis, non-Hodgkins lymphoma, hepatic metastases, brain tumour, others and Based on the distribu.Segmented by Distribution Channel;
hospitals, ambulatory surgical centres and cancer research institutes.Segmented by Geography;
North America, Europe, Asia Pacific, Middle East and Africa and Latin America - Report Timeline (2020 - 2030).Introduction
Global Therapeutic Nuclear Medicines Market (USD Million), 2020 - 2030
# | Global |
---|---|
2020 | 79.6 |
2021 | 89.4 |
2022 | 91.0 |
2023 | 105.6 |
2024 | 117.9 |
2025 | 118.4 |
2026 | 127.2 |
2027 | 141.5 |
2028 | 153.5 |
2029 | 166.3 |
2030 | 175.8 |
In the year 2023, the Global Therapeutic Nuclear Medicines Market was valued at USD 2,581.39 million. The size of this market is expected to increase to USD 7,840.56 million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of 17.2%.
Global Therapeutic Nuclear Medicines Market Report Snapshot
Parameters | Description |
---|---|
Market | Global Therapeutic Nuclear Medicines Market |
Study Period | 2020 - 2030 |
Base Year (for Therapeutic Nuclear Medicines Market Size Estimates) | 2023 |
Study Scope |
|
Market Segmentation |
|
Geographical Coverage |
|
Company Coverage |
|
Premium Insights |
|
Market Analysis
This report extensively covers different segments of Global Therapeutic Nuclear Medicines Market and provides an in depth analysis (including revenue analysis for both historic and forecast periods) for all the market segments. In this report, the analysis for every market segment is substantiated with relevant data points and, insights that are generated from analysis of these data points (data trends and patterns).
Global Therapeutic Nuclear Medicines Market Analysis
In this report, the Global Therapeutic Nuclear Medicines Market has been segmented by Treatment Type, Disease, Distribution Channel and Geography. India nuclear medicine market is a customer intelligence and competitive study of the demand, forecasts, trends, and macro indicators in india market. The dynamics including drivers, restraints, opportunities, political, socioeconomic factors, technological factors, key trends, and future prospects.
Global Therapeutic Nuclear Medicines Market, Segmentation by Treatment Type
The Global Therapeutic Nuclear Medicines Market has been segmented by Treatment Type into Radium-223, Iodine-131, Leutitium-177, Yttrium-90, Samarium-153, Strontium-89, Rhenium-188+ Rhenium-186, Erbium-169, Phosphorus-32 and others. The complete Global Therapeutic Nuclear Medicines Market segmentation by Treatment Type can be seen below:
- Global Therapeutic Nuclear Medicines Market, By Treatment Type
- Radium-223
- Iodine-131
- Leutitium-177
- Yttrium-90
- Samarium-153
- Strontium-89
- Rhenium-188+ Rhenium-186
- Erbium-169
- Phosphorus-32
- others
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Treatment Types mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Treatment Type is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Therapeutic Nuclear Medicines Market, by Treatment Type (USD Million), 2020 - 2030
# | Radium-223 | Iodine-131 | Leutitium-177 | Yttrium-90 | Samarium-153 | Strontium-89 | Rhenium-188+ Rhenium-186 | Erbium-169 | Phosphorus-32 | others |
---|---|---|---|---|---|---|---|---|---|---|
2020 | 78.0 | 71.0 | 93.2 | 61.4 | 95.9 | 56.8 | 96.6 | 93.0 | 103.5 | 85.4 |
2021 | 84.6 | 74.1 | 100.6 | 70.2 | 103.5 | 61.4 | 106.6 | 108.5 | 117.4 | 88.1 |
2022 | 96.9 | 80.2 | 108.8 | 79.9 | 109.9 | 72.4 | 114.8 | 123.7 | 123.3 | 89.4 |
2023 | 98.2 | 87.3 | 122.8 | 87.6 | 112.0 | 78.6 | 124.5 | 143.8 | 129.6 | 95.4 |
2024 | 109.1 | 88.7 | 143.4 | 94.9 | 116.4 | 88.7 | 139.2 | 168.9 | 152.6 | 102.9 |
2025 | 126.4 | 91.8 | 156.4 | 112.2 | 130.8 | 96.9 | 161.4 | 199.7 | 178.1 | 106.4 |
2026 | 136.9 | 104.3 | 165.2 | 115.2 | 142.1 | 107.7 | 161.5 | 228.4 | 182.0 | 115.2 |
2027 | 158.6 | 116.1 | 183.9 | 132.2 | 163.7 | 109.3 | 173.0 | 245.8 | 184.0 | 130.2 |
2028 | 168.0 | 128.8 | 208.3 | 135.1 | 181.5 | 130.5 | 188.2 | 283.7 | 217.4 | 153.8 |
2029 | 199.6 | 144.5 | 238.6 | 145.3 | 203.6 | 151.0 | 198.1 | 321.2 | 254.4 | 174.4 |
2030 | 212.0 | 168.5 | 244.9 | 158.4 | 206.6 | 156.9 | 209.7 | 348.3 | 271.8 | 187.5 |
Global Therapeutic Nuclear Medicines Market, Segmentation by Disease
The Global Therapeutic Nuclear Medicines Market has been segmented by Disease into prostate cancer, painful bone metastases, thyroid cancer, neuroblastoma, synovitis, non-Hodgkins lymphoma, hepatic metastases, brain tumour, others and Based on the distribu. The complete Global Therapeutic Nuclear Medicines Market segmentation by Disease can be seen below:
- Global Therapeutic Nuclear Medicines Market, By Disease
- prostate cancer
- painful bone metastases
- thyroid cancer
- neuroblastoma
- synovitis
- non-Hodgkins lymphoma
- hepatic metastases
- brain tumour
- others
- Based on the distribu
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Diseases mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Disease is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Therapeutic Nuclear Medicines Market, by Disease (USD Million), 2020 - 2030
# | prostate cancer | painful bone metastases | thyroid cancer | neuroblastoma | synovitis | non-Hodgkins lymphoma | hepatic metastases | brain tumour | others | Based on the distribu |
---|---|---|---|---|---|---|---|---|---|---|
2020 | 79.0 | 76.9 | 81.7 | 69.7 | 96.2 | 97.5 | 80.1 | 97.0 | 108.4 | 103.4 |
2021 | 84.7 | 85.5 | 95.4 | 74.3 | 97.8 | 107.4 | 82.1 | 98.0 | 110.2 | 103.9 |
2022 | 90.8 | 98.9 | 108.3 | 85.7 | 114.5 | 121.0 | 87.8 | 98.0 | 110.8 | 105.2 |
2023 | 105.6 | 107.4 | 114.4 | 101.4 | 115.0 | 133.2 | 88.9 | 114.5 | 127.6 | 125.0 |
2024 | 105.9 | 122.9 | 116.0 | 114.2 | 125.7 | 152.3 | 95.8 | 115.5 | 152.1 | 143.0 |
2025 | 111.4 | 129.5 | 126.3 | 132.7 | 127.9 | 161.1 | 100.2 | 132.3 | 166.2 | 157.8 |
2026 | 120.1 | 151.4 | 147.6 | 138.2 | 144.6 | 181.9 | 119.2 | 147.7 | 195.4 | 186.0 |
2027 | 120.1 | 159.5 | 161.7 | 156.0 | 159.5 | 202.3 | 119.4 | 176.2 | 226.1 | 187.9 |
2028 | 121.2 | 179.5 | 188.4 | 165.6 | 188.2 | 235.4 | 121.7 | 187.8 | 259.0 | 188.6 |
2029 | 124.1 | 187.1 | 213.7 | 188.1 | 213.7 | 239.3 | 131.1 | 224.3 | 302.9 | 197.1 |
2030 | 144.8 | 197.9 | 215.7 | 216.5 | 214.8 | 246.5 | 142.1 | 247.8 | 355.6 | 233.9 |
Global Therapeutic Nuclear Medicines Market, Segmentation by Distribution Channel
The Global Therapeutic Nuclear Medicines Market has been segmented by Distribution Channel into hospitals, ambulatory surgical centres and cancer research institutes. The complete Global Therapeutic Nuclear Medicines Market segmentation by Distribution Channel can be seen below:
- Global Therapeutic Nuclear Medicines Market, By Distribution Channel
- hospitals
- ambulatory surgical centres
- cancer research institutes
This report provides market size in USD Million and Year on Year (YOY) growth analysis for all the Distribution Channels mentioned above for historic (2020 - 2023) and forecast (2024 - 2030) periods with 2023 considered as the base year.
The report also provides an analysis of why the market size of the various segments by Distribution Channel is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Global Therapeutic Nuclear Medicines Market, by Distribution Channel (USD Million), 2020 - 2030
# | hospitals | ambulatory surgical centres | cancer research institutes |
---|---|---|---|
2020 | 95.9 | 82.1 | 94.2 |
2021 | 101.1 | 90.5 | 97.6 |
2022 | 105.7 | 103.6 | 116.1 |
2023 | 121.8 | 107.6 | 123.1 |
2024 | 131.4 | 127.4 | 140.2 |
2025 | 155.1 | 128.3 | 157.6 |
2026 | 167.0 | 130.9 | 182.7 |
2027 | 192.5 | 139.8 | 209.2 |
2028 | 210.2 | 146.2 | 244.1 |
2029 | 243.8 | 154.6 | 247.0 |
2030 | 282.0 | 182.3 | 274.8 |
Global Therapeutic Nuclear Medicines Market, Segmentation by Geography
In this report, the Global Therapeutic Nuclear Medicines Market has been segmented by Geography into five regions; North America, Europe, Asia Pacific, Middle East and Africa and Latin America.
Global Therapeutic Nuclear Medicines Market Share (%), by Geographical Region, 2023
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Find below the list of Countries covered in each of the aforementioned geographical regions:
North America - United States, Canada and Mexico
Latin America - Brazil, Argentina and Rest of Latin America
Europe - Germany, United Kingdom, France, Italy, Spain and Rest of Europe
Asia Pacific - Japan, China, India, Australia & New Zealand, South Korea, ASEAN (Association of South East Asian Nations) and Rest of Asia Pacific
Middle East & Africa - GCC Countries, Egypt, Israel, South Africa, Rest of Middle East & Africa
This report provides market size in USD Million and Year on Year (YOY) percentage growth analysis for the Therapeutic Nuclear Medicines Market in all the Regions and Countries (specified above) for historic (2020 - 2023) and forecast (2024 - 2030) Periods with 2023 considered as the base year.
This report also provides an analysis of why the market size of Therapeutic Nuclear Medicines in various regions and countries is increasing or decreasing with time along with the reasons for changes in the YOY growth with time.
Market Dynamics
This report provides an in depth analysis of various factors that impact the dynamics of Global Therapeutic Nuclear Medicines Market. These factors include; Market Drivers, Restraints and Opportunities Analysis, Market Opportunity Mapping, PEST (Political, Economic, Social and Technological) Analysis and Porter's Five Forces Analysis.
Drivers, Restraints and Opportunity Analysis
- The growth of the Global Therapeutic Nuclear Medicines Market is driven by; Supply Side Drivers and Demand Side Drivers.
- While the growth of Global Therapeutic Nuclear Medicines Market is currently hindered by; Trends.
- The new opportunities in Global Therapeutic Nuclear Medicines Market will be discussed in detail in the full report.
- Supply Side Drivers.
- Demand Side Drivers.
- Trends.
- Global Therapeutic Nuclear Medicines Market Opportunities will be discussed in detail in the full report.
Market Opportunity Map
This report provides market opportunity map for Therapeutic Nuclear Medicines Market. The opportunity map (by market segments; Treatment Type, Disease and Distribution Channel) is calculated based on current year market estimates, CAGR and collective revenue over the forecast period. Since, CAGR has been estimated considering all the factors impacting the market; starting from the company's presence, buyer behaviour, to government interference or support. The opportunity map inherently considers all the aforementioned factors impacting the market. The bubble size reflects the estimated opportunity for a particular segment or region, therefore, bigger the bubble size, larger the opportunity.
Global Therapeutic Nuclear Medicines Market, Opportunity Map, By Region (2020 - 2030)
North America | Europe | Asia Pacific | Middle East & Africa | Latin America |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
PEST (Political, Economic, Social and Technological) Analysis
This report provides PEST analysis of Therapeutic Nuclear Medicines Market. Various factors such as government interference in the market such as regulations (which include but are not limited to pricing and intellectual property policies) that might impact the market are analysed.
This report also provides an analysis of Economic factors affecting the market such as; purchasing power, which directly influences the market growth.
This report also provides an analysis of social factors such as social norms or cultural beliefs inhibiting or promoting the growth of the market
As part of PEST analysis, this report also provides analysis of the impact of Technological factors on growth or decline of a market.
- In depth analysis and insights about the impact of political factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of economic factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of social factors on this market will be provided in the final report.
- In depth analysis and insights about the impact of technological factors on this market will be provided in the final report.
Porter's Five Force Analysis
This report provides Porter's Five Forces analysis of Global Therapeutic Nuclear Medicines Market, which include; Bargaining Power of Suppliers, Bargaining Power of Buyers, Threat of New Entrants, Threat of Substitutes and Competitive Rivalry.
Bargaining Power of Suppliers:
Various factors such as; Supplier Switching Costs Relative to Firm Switching Costs, Supplier Competition and Possibility of Forward Integration, Presence of Substitute Inputs, Strength of Distribution Channels, and Supplier Concentration to Firm Concentration Ratio would be analysed to estimate bargaining power of suppliers in the Global Therapeutic Nuclear Medicines Market. Bargaining power of suppliers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value. The radiopharmaceutical industry has a lack of formalized good manufacturing practice (GMP) guidelines along with stringent policies governing the use of radiopharmaceuticals. However, to address the quality assurance concerns, nuclear medicine physicians are encouraging establishing centralized radio-pharmacies. Source: u.S. Bureau of labor statistics, occupational employment and wage statistics. The median annual wage for nuclear medicine technologists was $xxxx. The median wage is the wage at which half the workers in an occupation earned more than that amount and half earned less. Global alpha emitters market, by type of radionuclide. This study by tmr is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable cxos take effective decisions. Pharmaceutical market research. Closely tied to the healthcare industry, the pharmaceutical industry is also facing challenges, including pressure on drug pricing, regulation, changing healthcare models, and the growth of global drug manufacturing and sales. The radiopharmaceutical industry has a lack of formalized good manufacturing practice (GMP) guidelines along with stringent policies governing the use of radiopharmaceuticals. However, to address the quality assurance concerns, nuclear medicine physicians are encouraging establishing centralized radio-pharmacies. Because statistics is, in a sense, the heart of the scientific method, and because the field of statis tics, beginning with karl pearson and r. A. Fisher which consists of pharmaceutical market research, Alpha emitters market.
Bargaining Power of Suppliers
Supplier Switching Costs Relative To Firm Switching Costs | Strength of Distribution Channels | Supplier Concentration to firm Concentration Ratio | Presence of Substitute Inputs | Supplier Competition and Possibly of Forward Integration |
---|---|---|---|---|
20 | 10 | 15 | 5 | 50 |
Bargaining Power of Buyers:
Various factors such as; Buyer Concentration to Firm Concentration Ratio, Buyer Switching Costs, Availability of Existing Substitute Products, Buyer Price Sensitivity, and Degree of Dependency upon Existing Channels of Distribution would be analysed to estimate bargaining power of buyers in the Global Therapeutic Nuclear Medicines Market. Bargaining power of buyers will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Bargaining Power of Buyers
Buyer Competition to Firm Concentration Ratio | Buyer Switching Costs | Availability of existing Substitute Products | Buyer Price Sensitivity | Degree of Dependency upon Existing Channels of Distribution |
---|---|---|---|---|
10 | 15 | 25 | 45 | 32 |
Threat of Substitutes:
Various factors such as; Availability of Substitutes, Number of Available Substitutes, Price of Substitute Products, Buyer Switching Costs, and Buyer Propensity to Substitute would be analysed to estimate threat of substitutes in the Global Therapeutic Nuclear Medicines Market. Threat of substitutes will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of Substitutes:
Availability of Substitutes | Number of Available Substitutes | Price of Substitute Products | Buyer Switching Costs | Buyer Propensity to Substitute |
---|---|---|---|---|
20 | 35 | 10 | 2 | 5 |
Threat of New Entrants:
Various factors such as; Barriers to Entry, Economies of Scale, Product Differentiation, Customer Loyalty, Network Effect, and Access to Distribution Channels would be analysed to estimate threat of new entrants in the Global Therapeutic Nuclear Medicines Market. Threat of new entrants will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Threat of New Entrants:
Barriers to entry | Economics of scale | Product Differentiation | Customer Loyalty | Network Effect | Access to Ditribution Channels |
---|---|---|---|---|---|
2 | 35 | 25 | 10 | 15 | 55 |
Competitive Rivalry:
Various factors such as; Firm concentration Ratio, Level of Advertising Expense, Sustainable Competitive Advantage through Innovation, Competitive Strategy and Degree of Transparency would be analysed to estimate competitive rivalry in the Global Therapeutic Nuclear Medicines Market. Competitive rivalry will be reported on a scale of 0-10 with 0 being the lowest value and 10 being the highest value.
Industry Rivalry:
Firm Concentration Ratio | Level of Advertising Expense | Sustainable Competitive Adavantage through Innovation | Degree of Transparency | Competitive strategy |
---|---|---|---|---|
5 | 10 | 15 | 35 | 45 |
Competitive Landscape Analysis
Key players in Global Therapeutic Nuclear Medicines Market include, Bayer AG, Novartis AG, GE Healthcare, Curium Pharmaceuticals, Jubilant DraxImage, Spectrum Pharmaceuticals, Progenics Pharmaceuticals and ANSTO.
In this report, the profile of each market player provides following information:
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
Company SWOT Analysis
This report also provides Heat map analysis of Products/Services Offered by different companies operating in this market.
Competitors Products/Services Heat Map Analysis
Company Vs. Product/Service | Company 1 | Company 2 | Company 3 | Company 4 | Company 5 | Company 6 | Company 7 | Company 8 | Company 9 | Company 10 |
---|---|---|---|---|---|---|---|---|---|---|
Product 1/Service 1 | ||||||||||
Product 2/Service 2 | ||||||||||
Product 3/Service 3 | ||||||||||
Product 4/Service 4 | ||||||||||
Product 5/Service 5 | ||||||||||
Product 6/Service 6 | ||||||||||
Product 7/Service 7 | ||||||||||
Product 8/Service 8 |
- Introduction
- Research Objectives and Assumptions
- Research Methodology
- Abbreviations
- Market Definition & Study Scope
- Executive Summary
- Market Snapshot, By Treatment Type
- Market Snapshot, By Disease
- Market Snapshot, By Distribution Channel
- Market Snapshot, By Region
- Market Opportunity Map
- Global Therapeutic Nuclear Medicines Market Dynamics
- Drivers, Restraints and Opportunities
- Drivers
- Supply Side Drivers
- Demand Side Drivers
- Restraints
- Trends
- Opportunities
- Drivers
- Regulatory Scenario
- Reimbursement Scenario
- Mergers & Acquisitions, Collaborations & Partnerships, Agreements
- Pipeline Analysis/Technological Advancements
- PEST Analysis
- Political Analysis
- Economic Analysis
- Social Analysis
- Technological Analysis
- Porter's Analysis
- Bargaining Power of Suppliers
- Bragaining Power of Buyers
- Threat of Substitutes
- Threat of New Entrants
- Industry Rivalry
- Drivers, Restraints and Opportunities
- Market Segmentation
- Global Therapeutic Nuclear Medicines Market, By Treatment Type, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- Radium-223
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Iodine-131
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Leutitium-177
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Yttrium-90
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Samarium-153
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Strontium-89
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Rhenium-188+ Rhenium-186
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Erbium-169
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Phosphorus-32
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Radium-223
- Global Therapeutic Nuclear Medicines Market, By Disease, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- prostate cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- painful bone metastases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- thyroid cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- neuroblastoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- synovitis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- non-Hodgkins lymphoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- hepatic metastases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- brain tumour
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- Based on the distribu
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- prostate cancer
- Global Therapeutic Nuclear Medicines Market, By Distribution Channel, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Segment Trends
- hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- ambulatory surgical centres
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- cancer research institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020 - 2030 (USD Million)
- hospitals
- Global Therapeutic Nuclear Medicines Market, By Geography, 2022 - 2032 (USD Million)
- Introduction
- Market Share Analysis, 2024 and 2030 (%)
- Y-o-Y Growth Analysis, 2021 - 2030
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United States
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Canada
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United States
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Germany
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- United Kingdom
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- France
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Italy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Spain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Germany
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Japan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- China
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- India
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Australia & New Zealand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- South Korea
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- ASEAN (Association of South East Asian Countries)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Japan
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Brazil
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Brazil
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- GCC
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Israel
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- South Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- Rest of Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Disease, 2020 - 2030 (USD Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2020 - 2030 (USD Million)
- GCC
- North America
- Global Therapeutic Nuclear Medicines Market, By Treatment Type, 2022 - 2032 (USD Million)
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Bayer AG
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Novartis AG
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- GE Healthcare
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Curium Pharmaceuticals
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Jubilant DraxImage
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Spectrum Pharmaceuticals
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Progenics Pharmaceuticals, Inc.
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- ANSTO
- Company Overview and Product Portfolio
- Key Developments
- Financial Overview
- Strategies
- Company SWOT Analysis
- Bayer AG
- Analyst Views
- Future Outlook of the Market
ReAnIn's Most Viewed Titles:
In the year 2023, the Global Therapeutic Vaccines Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Thimbles Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Thoracic Vascular Stent Grafts Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%
In the year 2023, the Global Thoracolumbar Stabilization Devices Market was valued at USD xx.x million. The size of this market is expected to increase to USD xx.x million by the year 2030, while growing at a Compounded Annual Growth Rate (CAGR) of x.x%